Container
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of the container;
FIG. 2 is a right side elevational view thereof, the left side elevational view being a mirror image;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a rear elevational view thereof;
FIG. 5 is a top plan view thereof;
FIG. 6 is a bottom plan view thereof; and,
FIG. 7 is a perspective view thereof, the lid shown in open condition.
Claims
I claim the ornamental design for a container, as shown and described.
Referenced Cited
U.S. Patent Documents
D210067 | February 1968 | Abe |
D239596 | April 1976 | Dogliotti |
D296666 | July 12, 1988 | Hunt |
D318803 | August 6, 1991 | Bekius et al. |
D328014 | July 21, 1992 | DeCoster et al. |
D328710 | August 18, 1992 | Deflander |
5178308 | January 12, 1993 | Endre |
D340865 | November 2, 1993 | Endre |
6357945 | March 19, 2002 | Losier et al. |
D460696 | July 23, 2002 | Goettner |
D475286 | June 3, 2003 | Bomer |
D488383 | April 13, 2004 | Kudo et al. |
D506674 | June 28, 2005 | Sumiyoshi et al. |
Patent History
Patent number: D531905
Type: Grant
Filed: Mar 14, 2005
Date of Patent: Nov 14, 2006
Assignee: Glaxo Group Limited (Greenford)
Inventor: Peter Alan Day (Ascot)
Primary Examiner: Carol Rademaker
Attorney: Andrea D. Winslow
Application Number: 29/225,239
Type: Grant
Filed: Mar 14, 2005
Date of Patent: Nov 14, 2006
Assignee: Glaxo Group Limited (Greenford)
Inventor: Peter Alan Day (Ascot)
Primary Examiner: Carol Rademaker
Attorney: Andrea D. Winslow
Application Number: 29/225,239
Classifications
Current U.S. Class:
D9/522;
D9/526;
D9/529;
D9/543